| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,552 |
1,341 |
$101K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,252 |
1,109 |
$59K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
534 |
471 |
$40K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
948 |
871 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,115 |
914 |
$32K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
467 |
420 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
814 |
724 |
$13K |
| 99223 |
Prolong inpt eval add15 m |
77 |
77 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
59 |
59 |
$2K |
| 81025 |
|
305 |
267 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
63 |
53 |
$1K |
| 81002 |
|
430 |
383 |
$1K |
| 87807 |
|
104 |
101 |
$1K |
| 87808 |
|
68 |
56 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
18 |
$923.58 |
| 87905 |
|
69 |
58 |
$590.24 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
21 |
$235.44 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19 |
15 |
$46.84 |
| 36415 |
Collection of venous blood by venipuncture |
33 |
30 |
$20.50 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
38 |
29 |
$0.00 |
| 99000 |
|
15 |
13 |
$0.00 |